Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Alzheimers Dement. 2024 Jan 24. doi: 10.1002/alz.13674. Online ahead of print.
ABSTRACT
Despite its high prevalence among dementias, Lewy body dementia (LBD) remains poorly understood with a limited, albeit growing, evidence base. The public-health burden that LBD imposes is worsened by overlapping pathologies, which contribute to misdiagnosis, and lack of treatments. For this report, we gathered and analyzed public-domain information on advocacy, funding, research outputs, and the therapeutic pipeline to identify gaps in each of these key elements. To further understand the current gaps, we also conducted interviews with leading experts in regulatory/governmental agencies, LBD advocacy, academic research, and biopharmaceutical research, as well as with funding sources. We identified wide gaps across the entire landscape, the most critical being in research. Many of the experts participated in a workshop to discuss the prioritization of research areas with a view to accelerating therapeutic development and improving patient care. This white paper outlines the opportunities for bridging the major LBD gaps and creates the framework for collaboration in that endeavor. HIGHLIGHTS: A group representing academia, government, industry, and consulting expertise was convened to discuss current progress in Dementia with Lewy Body care and research. Consideration of expert opinion,natural language processing of the literature as well as publicly available data bases, and Delphi inspired discussion led to a proposed consensus document of priorities for the field.
PMID:38265159 | DOI:10.1002/alz.13674
![Google](https://www.google.com/images/branding/googlelogo/2x/googlelogo_light_color_92x30dp.png)
![Google Keep](https://www.gstatic.com/images/branding/product/1x/keep_48dp.png)
![Share on Linkedin](https://psychiatryai.com/wp-content/uploads/2023/10/linkedin-logo-png-2048-1.png)
Estimated reading time: 4 minute(s)
Latest: Psychiatryai.com #RAISR4D Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Cool Evidence: Engaging Young People and Students in Real-World Evidence
![](/wp-content/uploads/2024/04/bd462cc11bcf0bd0d0d6f1d0f8b7cd04-modified-1.png)
Real-Time Evidence Search [Psychiatry]
![](/wp-content/uploads/2024/04/pubmed.png)
AI Research
![](/wp-content/uploads/2024/05/Il5nR_nf_400x400-modified-1.png)
Lewy body dementia: Overcoming barriers and identifying solutions
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
🌐 90 Days
AI Virtual Reality Related Evidence Matrix
Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue Sympathetic 123I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging a-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies Remote Evaluation of Sleep and Circadian Rhythms in Older Adults With Mild Cognitive Impairment and Dementia: Protocol for a Feasibility and Acceptability Mixed Methods Study Ageing-Related Neurodegeneration and Cognitive Decline Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact Bidirectional two-sample Mendelian randomization analyses support causal relationships between structural and diffusion imaging-derived phenotypes and the risk of major neurodegenerative diseases Prevalence and Determinants of Diagnosed Dementia: A Registry Linkage Study Linking Diagnosis of Dementia in the Population-Based HUNT Study to Registry Diagnosis of Dementia in Primary Care and Hospitals in Norway Delineating cognitive resilience using fractal regulation: Cross-sectional and longitudinal evidence from the Rush Memory and Aging Project Revisiting the relevance of Hirano bodies in neurodegenerative diseases Experimental laboratory models as tools for understanding modifiable dementia risk Dementias Platform UK: Bringing genetics into life a-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City Dementia with Lewy bodies: Primary care PAs can make this difficult diagnosis Nurses' perspectives on shared decision-making in the daily care of hospitalized patients with dementia: An exploratory qualitative study Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology Causal relationship between dietary salt intake and dementia risk: Mendelian randomization study Understanding engagement in diet and dementia prevention research among British South Asians: a short report of findings from a patient and public involvement group MiRNA research-The potential for understanding the multiple facets of anorexia nervosa A systematic review/meta-analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian-American in ADRD research Characterization of monoamine oxidase-B (MAO-B) as a biomarker of reactive astrogliosis in Alzheimer's disease and related dementias Vaccine value profile for Klebsiella pneumoniae Promoting Healthy Aging to Reduce the Risk of Dementia: A Public Health Imperative A cross-sectional study of α-synuclein seed amplification assay in Alzheimer's disease neuroimaging initiative: Prevalence and associations with Alzheimer's disease biomarkers and cognitive function Enhanced Spine Stability and Survival Lead to Increases in Dendritic Spine Density as an Early Response to Local Alpha-Synuclein Overexpression in Mouse Prefrontal Cortex Decentralized clinical trials for medications to reduce the risk of dementia: Consensus report and guidance "I know now that it's something that you can do something about": Deductive thematic analysis of experiences at an arts-based dementia risk reduction exhibit Preparing Trainees for Public Health Advocacy Through Community Partnerships Nursing Home to Emergency Care Transition Form Has Limited Uptake But Improves Documentation The COVID-19 Vaccine Safety Research Center: a cornerstone for strengthening safety evidence for COVID-19 vaccination in the Republic of Korea Pimavanserin's Safety Profile: Insights from a Phase 3b Clinical Trial 20-year depressive symptoms, dementia, and structural neuropathology in older women Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer's Disease: A Pragmatic Review for Clinicians A qualitative study of the barriers to commissioning social and therapeutic horticulture in mental health care Plasma oxysterols are associated with serum lipids and dementia risk in older women Young-onset dementia with Lewy Bodies presenting with apathy and alexithymia The landscape of inequalities in dementia across Europe: First insights from the INTERDEM taskforce Influence of behavioral and psychological symptoms on caregiver burden for different types of dementia: clinical experience in Lima, Peru The role and impact of therapeutic counselling on the emotional experience of adults living with dementia: A systematic review Reduced cardiac 123I-MIBG uptake is a robust biomarker of Lewy body disease in isolated rapid eye movement sleep behaviour disorder Characteristics, outcomes, facilitators and barriers for psychosocial interventions on inpatient mental health dementia wards: a systematic review The impact of maternal smoking during pregnancy and the age of smoking initiation on incident dementia: A prospective cohort study Characteristics, outcomes, facilitators and barriers for psychosocial interventions on inpatient mental health dementia wards: a systematic review Outcomes of Patients With Mild Cognitive Impairment With Lewy Bodies or Alzheimer Disease at 3 and 5 Years After Diagnosis Living with dementia: Exploring the intersections of culture, race, and dementia, stigma A Qualitative Study Into the Relative Stigmatization of Mental Illness by Mental Health Professionals The changing dynamics of mixed health systems in low- and middle-income countries The Body, the Brain, the Environment, and Parkinson's Disease Long-term impact of type 2 diabetes onset on dementia incidence rate among New Zealanders with impaired glucose tolerance: A tapered-matched landmark analysis over 25 years Report of a Meeting: Food, Nutrition, and Autism: From Soil to Fork Mitochondrial DNA deletions in the cerebrospinal fluid of patients with idiopathic REM sleep behaviour disorder Differences in cognitive trajectories of dementia: Comparison Alzheimer's disease dementia and Dementia with Lewy bodies in Korean patient cohort Associations of hospital-treated infections with subsequent dementia: nationwide 30-year analysis Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice Lifestyle and incident dementia: A COSMIC individual participant data meta‐analysis Unconventional data, unprecedented insights: leveraging non-traditional data during a pandemic Conjugal Synucleinopathies: A Clinicopathologic Study
Evidence Blueprint
Lewy body dementia: Overcoming barriers and identifying solutions
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
☊ AI-Driven Related Evidence Nodes
(recent articles with at least 5 words in title)
More Evidence
![](https://psychiatryai.com/wp-content/uploads/2023/04/psychiatryai_com.webp)
Lewy body dementia: Overcoming barriers and identifying solutions
🌐 365 Days
AI Virtual Reality Related Evidence Matrix
Lewy Body Dementias: Controversies and Drug Development Sex differences for clinical correlates of substantia nigra neuron loss in people with Lewy body pathology Neuropsychiatric symptoms profile and markers of Alzheimer disease-type pathology in patients with Lewy body dementias Structure of alpha-synuclein fibrils derived from human Lewy body dementia tissue Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders Targeting Lewy body dementia with neflamapimod-rasagiline hybrids HLA in isolated REM sleep behavior disorder and Lewy body dementia Identifying individuals with non-Alzheimer's disease co-pathologies: A precision medicine approach to clinical trials in sporadic Alzheimer's disease Sympathetic 123I-metaiodobenzylguanidine index for Lewy body disease: probability-based diagnosis and identifying patients exempt from late imaging a-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway Genome-wide structural variant analysis identifies risk loci for non-Alzheimer's dementias Gray matter loss relates to dual task gait in Lewy body disorders and aging G272V and P301L mutations induce isoform specific tau mislocalization to dendritic spines and synaptic dysfunctions in cellular models of 3R and 4R tau frontotemporal dementia Cardiac noradrenergic deficiency revealed by 18F-dopamine positron emission tomography identifies preclinical central Lewy body diseases Differential Vulnerability of Hippocampal Subfields to Amyloid and Tau Deposition in the Lewy Body Diseases Disease and brain region specific immune response profiles in neurodegenerative diseases with pure and mixed protein pathologies Specific neuropsychiatric symptoms are associated with functional decline trajectories in Alzheimer's disease and Lewy body dementia: a five-year follow-up study Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies Remote Evaluation of Sleep and Circadian Rhythms in Older Adults With Mild Cognitive Impairment and Dementia: Protocol for a Feasibility and Acceptability Mixed Methods Study Elucidating distinct molecular signatures of Lewy body dementias Ageing-Related Neurodegeneration and Cognitive Decline Apathy in Lewy body disease and its effects on functional impairment over time Association of Parkinson's disease to Parkinson's plus syndromes, Lewy body dementia, and Alzheimer's dementia Disentangling and quantifying the relative cognitive impact of concurrent mixed neurodegenerative pathologies Lewy body pathology modifies risk factors for cerebral amyloid angiopathy when comorbid with Alzheimer's disease pathology Different cohort, disparate results: Selection bias is a key factor in autopsy cohorts Artificial intelligence for dementia genetics and omics Diagnostic performance of molecular imaging methods in predicting the progression from mild cognitive impairment to dementia: an updated systematic review The 2022 symposium on dementia and brain aging in low- and middle-income countries: Highlights on research, diagnosis, care, and impact Reframing motherhood in dementia research: A call for action Relative contributions of mixed pathologies to cognitive and functional symptoms in brain donors exposed to repetitive head impacts Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay Inhibition of autophagic flux by S-nitrosylation of SQSTM1/p62 promotes neuronal secretion and cell-to-cell transmission of SNCA/α-synuclein in Parkinson disease and Lewy body dementia Bidirectional two-sample Mendelian randomization analyses support causal relationships between structural and diffusion imaging-derived phenotypes and the risk of major neurodegenerative diseases Increasing sensitivity of clinical proverb tests for diagnosis of dementia Reply to Kljajevic's "Increasing sensitivity of clinical proverb tests for diagnosis of dementia" Prevalence and Determinants of Diagnosed Dementia: A Registry Linkage Study Linking Diagnosis of Dementia in the Population-Based HUNT Study to Registry Diagnosis of Dementia in Primary Care and Hospitals in Norway Delineating cognitive resilience using fractal regulation: Cross-sectional and longitudinal evidence from the Rush Memory and Aging Project Walking the talk for dementia: A unique immersive, embodied, and multi-experiential initiative Getting to the heart of Lewy body disease Longitudinal motor decline in dementia with Lewy bodies, Parkinson disease dementia, and Alzheimer's dementia in a community autopsy cohort Artificial intelligence for dementia drug discovery and trials optimization Frontotemporal dementia: Past, present, and future Revisiting the relevance of Hirano bodies in neurodegenerative diseases Experimental laboratory models as tools for understanding modifiable dementia risk Dementias Platform UK: Bringing genetics into life ATN cerebrospinal fluid biomarkers in dementia with Lewy bodies: Initial results from the United States Dementia with Lewy Bodies Consortium a-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden Advancements in dementia research, diagnostics, and care in Latin America: Highlights from the 2023 Alzheimer's Association International conference satellite symposium in Mexico City Algorithmic identification of persons with dementia for research recruitment: ethical considerations Dementia in South Africa: A Situational Analysis Dysphagia in a Patient With Lewy Body Dementia and Incidental Anterior Cervical Osteophyte: A Case Report The androgen receptor Dementia with Lewy bodies: Primary care PAs can make this difficult diagnosis A strategic neurological research agenda for Europe: Towards clinically relevant and patient-centred neurological research priorities Nurses' perspectives on shared decision-making in the daily care of hospitalized patients with dementia: An exploratory qualitative study Liver integrity and the risk of Alzheimer's disease and related dementias Brain Bank Questionnaire Helps in Differential Diagnosis of Movement Disorders: An Autopsy Study of 150 Patients Associations of blood cell indices and anemia with risk of incident dementia Authors' response to: A new dementia prevention approach requires new language Care sequences leading to the diagnosis of Alzheimer's disease and related dementias: An analysis of electronic health records INviting Veterans InTo Enrollment in Alzheimer's Disease Research Centers (INVITE-ADRC): An NIA and VA-sponsored initiative to increase veteran participation in aging and dementia research "Association of blood cell indices and anemia with risk of incident dementia": Missing important covariates in MRI analysis may be misleading Artificial intelligence for dementia research methods optimization